Your browser doesn't support javascript.
loading
Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.
Chiorean, Andreea; Farncombe, Kirsten M; Delong, Sean; Andric, Veronica; Ansar, Safa; Chan, Clarissa; Clark, Kaitlin; Danos, Arpad M; Gao, Yizhuo; Giles, Rachel H; Goldenberg, Anna; Jani, Payal; Krysiak, Kilannin; Kujan, Lynzey; Macpherson, Samantha; Maher, Eamonn R; McCoy, Liam G; Salama, Yasser; Saliba, Jason; Sheta, Lana; Griffith, Malachi; Griffith, Obi L; Erdman, Lauren; Ramani, Arun; Kim, Raymond H.
Afiliação
  • Chiorean A; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Farncombe KM; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Delong S; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Andric V; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Ansar S; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Chan C; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Clark K; Department of Medicine, Division of Oncology, Washington University School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Danos AM; McDonnell Genome Institute, Washington University School of Medicine, Missouri, St. Louis, USA.
  • Gao Y; Department of Medicine, Division of Oncology, Washington University School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Giles RH; McDonnell Genome Institute, Washington University School of Medicine, Missouri, St. Louis, USA.
  • Goldenberg A; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Jani P; International Kidney Cancer Coalition, Duivendrecht-Amsterdam, Duivendrecht, The Netherlands.
  • Krysiak K; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Kujan L; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Macpherson S; Department of Medicine, Division of Oncology, Washington University School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Maher ER; McDonnell Genome Institute, Washington University School of Medicine, Missouri, St. Louis, USA.
  • McCoy LG; Department of Medicine, Division of Oncology, Washington University School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Salama Y; McDonnell Genome Institute, Washington University School of Medicine, Missouri, St. Louis, USA.
  • Saliba J; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Sheta L; Department of Medical Genetics, University of Cambridge, Cambridge, UK.
  • Griffith M; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Griffith OL; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Erdman L; Department of Medicine, Division of Medical Oncology, University Health Network, Toronto, Ontario, Canada.
  • Ramani A; Department of Medicine, Division of Oncology, Washington University School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Kim RH; McDonnell Genome Institute, Washington University School of Medicine, Missouri, St. Louis, USA.
Hum Mutat ; 43(9): 1268-1285, 2022 09.
Article em En | MEDLINE | ID: mdl-35475554
ABSTRACT
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome where individuals are predisposed to tumor development in the brain, adrenal gland, kidney, and other organs. It is caused by pathogenic variants in the VHL tumor suppressor gene. Standardized disease information has been difficult to collect due to the rarity and diversity of VHL patients. Over 4100 unique articles published until October 2019 were screened for germline genotype-phenotype data. Patient data were translated into standardized descriptions using Human Genome Variation Society gene variant nomenclature and Human Phenotype Ontology terms and has been manually curated into an open-access knowledgebase called Clinical Interpretation of Variants in Cancer. In total, 634 unique VHL variants, 2882 patients, and 1991 families from 427 papers were captured. We identified relationship trends between phenotype and genotype data using classic statistical methods and spectral clustering unsupervised learning. Our analyses reveal earlier onset of pheochromocytoma/paraganglioma and retinal angiomas, phenotype co-occurrences and genotype-phenotype correlations including hotspots. It confirms existing VHL associations and can be used to identify new patterns and associations in VHL disease. Our database serves as an aggregate knowledge translation tool to facilitate sharing information about the pathogenicity of VHL variants.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Suprarrenais / Doença de von Hippel-Lindau Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Suprarrenais / Doença de von Hippel-Lindau Idioma: En Ano de publicação: 2022 Tipo de documento: Article